These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31681176)

  • 1. A Comparison of Doppler Flow Parameters in the Ophthalmic Artery and Central Retinal Artery in Patients With Graves' Disease and Toxic Nodular Goiter.
    Walasik-Szemplińska D; Kamiński G; Mańczak M; Widłak J; Sudoł-Szopińska I
    Front Endocrinol (Lausanne); 2019; 10():707. PubMed ID: 31681176
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Radioiodine Treatment on Doppler Flow Parameters in the Central Retinal Artery and Ophthalmic Artery in Patients With Hyperthyroidism.
    Walasik-Szemplińska D; Kamiński G; Sudoł-Szopińska I
    J Ultrasound Med; 2021 Feb; 40(2):305-318. PubMed ID: 32697397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graves' ophthalmopathy: comparison of the Doppler sonography parameters with the clinical activity score.
    Yanik B; Conkbayir I; Acaroglu G; Hekimoglu B
    J Clin Ultrasound; 2005 Oct; 33(8):375-80. PubMed ID: 16240428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis of hyperthyroidism: Doppler sonographic quantification of thyroid blood flow distinguishes between Graves' disease and diffuse toxic goiter.
    Saleh A; Cohnen M; Fürst G; Godehardt E; Mödder U; Feldkamp J
    Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):32-6. PubMed ID: 11835123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doppler imaging of orbital vessels in the assessment of the activity and severity of thyroid-associated orbitopathy.
    Walasik-Szemplińska D; Pauk-Domańska M; Sanocka U; Sudoł-Szopińska I
    J Ultrason; 2015 Dec; 15(63):388-97. PubMed ID: 26807296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation.
    Alp MN; Ozgen A; Can I; Cakar P; Gunalp I
    Br J Ophthalmol; 2000 Sep; 84(9):1027-30. PubMed ID: 10966959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study.
    Cramon P; Winther KH; Watt T; Bonnema SJ; Bjorner JB; Ekholm O; Groenvold M; Hegedüs L; Feldt-Rasmussen U; Rasmussen ÅK
    Thyroid; 2016 Aug; 26(8):1010-8. PubMed ID: 27370744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doppler ultrasonographic measurement of short-term effects of valsalva maneuver on retrobulbar blood flow.
    Kimyon S; Mete A; Mete A; Mete D
    J Clin Ultrasound; 2017 Nov; 45(9):551-555. PubMed ID: 28440860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrobulbar ocular blood flow changes after orbital decompression in Graves' ophthalmopathy measured by color Doppler imaging.
    Pérez-López M; Sales-Sanz M; Rebolleda G; Casas-Llera P; González-Gordaliza C; Jarrín E; Muñoz-Negrete FJ
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5612-7. PubMed ID: 21498614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colour Doppler imaging and fluorescein filling defects of the optic disc in normal tension glaucoma.
    Plange N; Remky A; Arend O
    Br J Ophthalmol; 2003 Jun; 87(6):731-6. PubMed ID: 12770971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Color Doppler evaluation of the ocular arterial flow changes in chronic obstructive pulmonary disease.
    Ozer T; Altin R; Ugurbas SH; Ozer Y; Mahmutyazicioglu K; Kart L
    Eur J Radiol; 2006 Jan; 57(1):63-8. PubMed ID: 16051458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between choroidal vascularity and retrobulbar ocular blood flow changes and thyroid-associated ophthalmopathy activity: a cross-sectional study.
    Sun X; Su M; Zhang X; Shen H; Xie Z; Kong W; Zhu D
    BMC Ophthalmol; 2024 Feb; 24(1):64. PubMed ID: 38350897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Color doppler imaging of ocular hemodynamic changes in Behçet's disease.
    Caça I; Nazaroğlu H; Unlü K; Cakmak SS; Ari S; Sakalar YB
    Jpn J Ophthalmol; 2004; 48(2):101-5. PubMed ID: 15060789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Color Doppler imaging in thyroid eye disease and its correlation to disease activity.
    Jamshidian-Tehrani M; Nabavi A; Kasaee A; Hasanpoor N; Elhami E; Sharif-Kashani S; Masoumi A; Nowroozzadeh MH; Sadeghi-Tari A
    Orbit; 2019 Dec; 38(6):440-445. PubMed ID: 30628510
    [No Abstract]   [Full Text] [Related]  

  • 15. Sequential occurrence of toxic nodular goiter followed by Graves' disease.
    Seplowitz AH; Ditkoff BA; Papadopoulos AD; Gerfo PL
    Endocr Pract; 1998; 4(3):150-2. PubMed ID: 15251744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Utility of Mean Peak Systolic Velocity of Superior Thyroid Artery in Differentiating Graves' Disease from Thyroiditis.
    Sarangi PK; Parida S; Mangaraj S; Mohanty BK; Mohanty J; Swain BM
    Indian J Radiol Imaging; 2021 Apr; 31(2):311-317. PubMed ID: 34556913
    [No Abstract]   [Full Text] [Related]  

  • 17. Reproducibility of color Doppler imaging in orbital vessels.
    Senn BC; Kaiser HJ; Schötzau A; Flammer J
    Ger J Ophthalmol; 1996 Nov; 5(6):386-91. PubMed ID: 9479523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter.
    Giesecke P; Rosenqvist M; Frykman V; Friberg L; Wallin G; Höijer J; Lönn S; Törring O
    Thyroid; 2017 Jul; 27(7):878-885. PubMed ID: 28471268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of blood flow velocity in eyeball arteries in multiple sclerosis patients with past retrobulbar optic neuritis in color Doppler ultrasonography.
    Modrzejewska M; Karczewicz D; Wilk G
    Klin Oczna; 2007; 109(4-6):183-6. PubMed ID: 17725282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U; Gerber H; Peter HJ
    Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.